Reuters logo
BRIEF-Intrexon Corp says initial studies validates efficacy of dsRNA for insect control applications using its proprietary ActoBiotics platform
December 13, 2016 / 1:23 PM / 10 months ago

BRIEF-Intrexon Corp says initial studies validates efficacy of dsRNA for insect control applications using its proprietary ActoBiotics platform

Dec 13 (Reuters) - Intrexon Corp :

* Intrexon Corp - initial studies have validated efficacy of dsRNA for insect control applications using its proprietary ActoBiotics platform Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below